Addition of 0.1 per cent MER-13 to an atherogenic, high-cholesterol diet largely prevented the development of hypercholesteremia and aortic and coronary artery atheromatosis in cockerels. The hypocholestereinic effect was not obtained when MER-13 was administered following the removal of cholesterol from the diet. It is concluded that MER-13 inhibits absorption of cholesterol from the gastrointestinal tract.
ery and raised in the laboratory. When 12 weeks old they were placed upon the experimental diets. Diets were mixed by adding the supplements individually to growing mash in a Hobart mixer. They were fed ad libitum.
Records were kept of food consumption and body weight. Comb measurements were taken at the start of the experiment and at sacrifice. The birds were sacrificed between 50 and 53 days after beginning the experiment, a bird being taken from each group in turn. At autopsy, the heart and aorta (including the brachiocephalic arteries and the iliac arteries approximately 1 cm. below the aortic bifurcation) were removed for examination. Weights of the testes were recorded and notation made of the gross appearance of the liver, portions of which were preserved in formalin for microscopic examination.
Aortic atherosclerosis was graded on a 0 to 4 plus basis according to criteria listed by Katz and Stamler. 1 Grading was done at autopsy and again after formalin fixation and staining with Oil Red 0. Values obtained by the two methods were essentially the same. Coronary atherosclerosis was graded on frozen sections of the left ventricle and the interventricular septum, stained with Sudan IV and hematoxylin. A minimum of 25 coronary artery sections was counted from each heart. This grading was carried out by a single person who did not know the identity of the sections until grading was complete.
Blood samples (10 ml.) were drawn from the heart for lipid analysis; clotting was prevented with 0.1 ml. of heparin solution. Plasma total cholesterol was measured by either of two methods: that of Abell, Levy, Brodie and Kendall* or that of Sperry and Webb.' The two methods have given equivalent results in this laboratory. Addition of an equal weight of MER-13 to cholesterol 
RESULTS
Effects of MEB-13 on Plasma Lipids and Atherogenesis. Ten cockerels were fed a diet consisting of growing mash plus 1 per cent cholesterol and 5 per cent cottonseed oil; this was the control group (group C). Eleven cockerels (group M) received this diet plus 0.1 per cent . Plasma lipid levels are given in table 1. The birds of group C exhibited the rise of free and total cholesterol* and phospholipids in plasma characteristic of cholesterol-fed chickens. Group M birds exhibited a rise in the cholesterol fractions also, but the average values of these were at all times significantly less (1 per cent level) than for the control group. At 43 days two birds had "escaped" from the effect of MER-13, attaining total cholesterol levels of 1350 and 1690 mg. per cent. The total cholesterol levels of the other 9 birds of group M decreased or remained the same *The plasma lipids before cholesterol feeding were not obtained on these birds, but 20 other chicks from the same hatch had an average plasma total cholesterol of 102 mg. per cent 2 weeks prior to the start of this experiment. during this period. Plasma phospholipids did not rise in group M; this may have been due to the same causes as the lag of hyperphospholipemia behind hypercholesteremia seen in the control group at 8 days. The ratio of cholesterol to phospholipid remained lower in group M than in group C, nevertheless. Although neither plasma total lipids nor neutral fat were measured, plasma turbidity was markedly reduced in group M.
Gradings of aortic and coronary atherosclerosis are presented iii table 2. The incidence of lesions in the thoracic portion of the aorta and in the coronary arteries was much lower in MER-13 treated birds than in the control group. Severity of lesions was reduced in both portions of the aorta in group M. A possible explanation for the similar incidence of abdominal aortic lesions in the two groups is the fact that this area is the site of spontaneous lesions in the chicken. Such lesions develop in birds on a cholesterol-free diet, but become foci for lipid deposition in cholesterol-fed birds. In the coronary arteries, "incidence" signifies the per cent of the arterial sections exhibiting atheroma. Coronary lesions in group C birds consisted of intimal thickenings, foam cell "cushions" and plaques, which in a number of cases partly occluded the lumen. In the group M birds, the lesions consisted mostly of slight thickenings of the intima and occasional plaques. Fatty infiltration of the ar- terial wall, without evidence of tissue reaction or abnormality, was not considered to constitute a lesion; however, this finding was also less common in the birds which received MER-13 than in controls.
At autopsy it was noted that the colors of the livers of the group M birds were more nearly normal than in group C birds. The latter exhibited the typical yellow, fatty livers of cholesterol-fed chickens, whereas those of group M were nearly all brown or red. Microscopic evaluation of liver sections stained for fat failed to reveal any significant difference between the two groups, however.* Pood consumption was equal for the groups. Body weight gain, comb measurements and testes weights are given in table 3. There were no significant differences between the groups in these measurements.
Mechanistn of Hie Hypocholesteremic Effect of . Most of the substances which produce a hypocholesteremic effect under these experimental conditions interfere with absorption of cholesterol from the intestine. 0 " 10 Such an effect could also be achieved through: A. Increasing the rate of disposal of absorbed cholesterol through increased excretion or increased eatabolisrn. B. Decreasing the endogenous production of cholesterol. sites. D. Chemical reaction between the drug and cholesterol, resulting in a change in the biologic and analytic characteristics of the latter.
There was no evidence for mechanism C, since at autopsy all organs were of normal size and appearance. Likewise, no evidence exists for mechanism D, since MER-13 did not interfere in the digitonin precipitation oi-Liebermann-Burchard determination of cholesterol. It does not seem likely that an effect on endogenous synthesis of cholesterol could account quantitatively for the reduction in plasma cholesterol which was found. Under the experimental conditions, endogenous cholesterol synthesis would have been depressed almost to zero due to the dietary cholesterol alone, assuming that the chicken possesses a homeostatic mechanism for the regulation of blood cholesterol similar to that found in mammals. 11 " 13 It therefore seemed likely that MER-13 either inhibits cholesterol absorption or increases the rate of its disposal after it is absorbed. Determination of the effect of MER-13 on the rate of decline of established hypercholesteremia should distinguish between these two modes of action. which contained 85 per cent /3-sitosterol. This preparation had been shown in previous experiments to be completely effective in preventing hypercholesteremia due to a 1 per cent cholesterol diet, when fed as 2 per cent of the diet. Blood was taken for cholesterol determination at 3, 7, and 12 days. Results are given in figure 1 . Neither MER-13 nor cottonseed sterols increased the rate of regression of hypercholestereruia. There was some indication of a retarding effect, although this was not statistically significant by the t test at any of the samplings. This may have been due to reduced food intake in the birds receiving MER-13 and sitosterol. Food consumption of the MER-13 treated birds was 70 per cent, and of the sitosterol-treated birds, 83 per cent, of the value for the control group. Undernutrition has been shown to enhance and prolong hypercholesteremia in chickens. 14 No evidence of diarrhea has been seen in chickens fed MER-13 up to levels of 0.2 percent, the highest percentage used in the diet. DISCUSSION MER-13 strongly inhibited the development of hypercholesteremia and aortic and coro-nary atherosclerosis in cholesterol-fed chickens. Once hypercholesteremia was established, neither MER-13 nor sitosterol increased the rate at which blood cholesterol levels returned to normal after cholesterol feeding was stopped. Thus MER-13 does not increase the rate of disposal of circulating cholesterol through increased excretion or catabolism. It can also be concluded that the inhibition of development of hypercholesteremia observed in the first experiment could not have been clue to an effect of MER-13 on cholesterol biosynthesis. Thus if inhibition of endogenous cholesterol biosynthesis had played an important role in prevention of hypercholesteremia during the experiment in which cholesterol was continuously fed, it should certainly have produced a measurable hypocholesteremic effect in the second experiment, when the exogenous cholesterol load was removed. Even if MER-13 affects cholesterol biosynthesis, it can be concluded that the inhibition of dietary hypercholesteremia observed in our initial experiment must have been due to inhibition of absorption of cholesterol from the gastrointestinal tract, i.e., an effect on the exogenous source of blood cholesterol. These conclusions are strengthened by the similarity of effects obtained with and sitosterol in our experiments. Gould 18 has shown by means of tracer experiments that /?-sitosterol inhibits absorption of cholesterol from the intestine, but does not affect its biosynthesis in the liver.
Numerous investigators have shown that orally administered /9-sitosterol reduces hypercholesteremia in man, indicating that interference with intestinal absorption of cholesterol raaj r be a practical approach to the reduction of excessive blood cholesterol. Sitosterol and other steroid inhibitors of cholesterol absorption suffer from several therapeutic disadvantages. Very large doses of these materials are required, ranging from 9 to 30 Gm./day. It has been shown that the feeding of soy sterols or of dihydrocholesterol can produce in experimental animals the disease (atherosclerosis) which they are intended to prevent. 16 ' 17 It seems likely that the extreme insolubility 18 and the metabolic inertness of sterols in most extrahepatic tissues can be held largely responsible for their accumulation in arterial intimal tissue. It seems reasonable to hope that these undesirable characteristics may be circumvented with an agent such as which is more potent than /3-sitosterol in preventing hypercholesteremia in cholesterol-fed chickens, and is soluble in water to the extent of approximately 1 per cent. SUMMARY A synthetic compound, l,l-bis-(p-methoxyphenyl) -2-(p-guanylphenyl) -ethylene hydrochloride (MER-13), given in the diet at a level of 0.1 per cent, inhibited the development of hypercholesteremia and aortic and coronary atherosclerosis in cholesterol-fed cockerels. Under these conditions it had no effect on food consumption, body weight, comb size or testes weight. MER-13, like /3-sitosterol, did not increase the rate of regression of established hypercholesteremia in chickens, when cholesterol was removed from the diet. It is probable that it inhibits intestinal absorption of cholesterol. Because of its water solubility and potency, or similar materials may possess therapeutic advantages over steroid inhibitors of cholesterol absorption.
SUMMAB10 IN INTERL1NGUA
Le composito synthetic, hydrochloruro de 1,1 -bis -(p -methoxyphenyl) -2 -(p -guanylphenyl) ethyleno (MER-13), administrate in le dieta in un concentration de 0,1 procento, inhibiva le disveloppamento de hypercholesterolemia e de atherosclerosis aortic e coronari in juvene gallos que recipeva dosages dietari de cholesterol. Sub iste conditiones, le consumption de alimentos, le pesos corporee, le dimensiones del cresta, e le peso del testes remaneva normal. MER-13, como sitosterol beta, non accelerava le regression de previemente establite hypercholesterolemia in gallinas quando le addition de cholesterol al dieta esseva eliminate. II se probabile que illo inhibi le absorption intestinal de cholesterol. A causa de su hydrosolubilitate e su potentia, MER-13 o simile composites possede possibilemente avantages therapeutic in coniparation con le steroide inhibitores del absorption de cholesterol.
